Cargando…
Anchoring IgG-degrading enzymes to the surface of platelets selectively neutralizes antiplatelet antibodies
Immune thrombocytopenia (ITP) is an acquired bleeding disorder characterized by immunoglobulin G (IgG)–mediated platelet destruction. Current therapies primarily focus on reducing antiplatelet antibodies using immunosuppression or increasing platelet production with thrombopoietin mimetics. However,...
Autores principales: | Lynch, Donald R., Stringham, Emily N., Zhang, Boya, Balbin-Cuesta, Ginette, Curtis, Brian R., Palumbo, Joseph S., Greineder, Colin F., Tourdot, Benjamin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636316/ https://www.ncbi.nlm.nih.gov/pubmed/35737875 http://dx.doi.org/10.1182/bloodadvances.2022007195 |
Ejemplares similares
-
Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets
por: Bye, Alexander P., et al.
Publicado: (2021) -
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
por: Hottz, Eugenio D., et al.
Publicado: (2020) -
Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia
por: Li, Na, et al.
Publicado: (2021) -
Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry
por: Kemble, Samuel, et al.
Publicado: (2022) -
The fate of mitochondria during platelet activation
por: Grichine, Alexei, et al.
Publicado: (2023)